Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention
Isn’t it a little disappointing that, while many clinicians don’t even realize that homocysteine is an independent risk factor for cardiovascular disease, we have moved beyond acceptance to clinical outcomes. The fact that an intervention as simple, cheap and safe as specific vitamin supplementation lowering risk of CVD makes this a no-brainer from a clinician’s standpoint.